Search hospitals > Massachusetts > Boston
Beth Israel Deaconess Medical Center
Claim this profileBoston, Massachusetts 02215
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Pancreatic Cancer
Conducts research for Prostate Cancer
2097 reported clinical trials
158 medical researchers
Summary
Beth Israel Deaconess Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer and other specialties. Beth Israel Deaconess Medical Center is involved with conducting 2,097 clinical trials across 1,674 conditions. There are 158 research doctors associated with this hospital, such as Geoffrey I. Shapiro, Gregory Cote, MD, Jon Arnason, MD, and Andrea J Bullock, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
2Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
Geoffrey I. ShapiroDana-Farber Cancer Institute8 years of reported clinical research
Expert in Cancer
Expert in Pancreatic Cancer
27 reported clinical trials
57 drugs studied
Gregory Cote, MDMassachusetts General Hospital7 years of reported clinical research
Studies Cancer
Studies Soft Tissue Sarcoma
19 reported clinical trials
27 drugs studied
Jon Arnason, MDBeth Israel Deaconess Medical Center1 year of reported clinical research
Expert in Lymphoma
Studies Chronic Lymphocytic Leukemia
15 reported clinical trials
24 drugs studied
Andrea J Bullock, MDBeth Israel Deaconess Medical Center3 years of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
14 reported clinical trials
34 drugs studied
Clinical Trials running at Beth Israel Deaconess Medical Center
Breast Cancer
Lung Cancer
Multiple Myeloma
Prostate Cancer
Breast cancer
Cancer
Lymphoma
Stroke
Pulmonary Embolism
Ovarian Cancer
Gadolinium-Based Contrast Media Effects on Motor and Cognitive Functioning
for undefined
This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mouth. In this study researchers want to find out whether so called gadolinium-based contrast agents (GBCAs) have an effect on body movement and mental skills when given to participants multiple times within 5 years. The study plans to enroll about 2076 participants suffering from a condition for which they are likely to have at least annually a MRI or another imaging examinations. Only adults up to 65 years will be considered to join this study. During the study duration of 5 years participants will receive annually a MRI or other imaging tests (such as CT-scan, x-ray) and will visit the study doctor at least 7 times for physical examinations, laboratory investigations and tests on body movement and mental skills.
Recruiting3 awards Phase 49 criteria
Sacituzumab Govitecan + Pembrolizumab
for Breast Cancer
This research study is studying to evaluate sacituzumab govitecan for individuals with localized triple negative breast cancer (TNBC) The names of the study drugs involved in this study is: * Sacituzumab govitecan (SG) * Pembrolizumab (combination therapy with SG)
Recruiting2 awards Phase 211 criteria
Gedatolisib + Fulvestrant +/- Palbociclib
for Advanced Breast Cancer
This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Beth Israel Deaconess Medical Center?
Beth Israel Deaconess Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer and other specialties. Beth Israel Deaconess Medical Center is involved with conducting 2,097 clinical trials across 1,674 conditions. There are 158 research doctors associated with this hospital, such as Geoffrey I. Shapiro, Gregory Cote, MD, Jon Arnason, MD, and Andrea J Bullock, MD.
Where is Beth Israel Deaconess Medical Center located?
**Directions to Beth Israel Deaconess Medical Center, Boston:**
- **Main Entrance:** From I-90 E or I-93 N, take exit 16B towards Storrow Drive. Continue on Storrow Drive, take the Fenway/Kenmore exit, follow signs for Boylston Street Inner Belt, turn right onto Boylston Street, and then left onto Brookline Avenue. The medical center is located at 330 Brookline Avenue.
- **Emergency Room:** For emergency services, set your destination to 1 Deaconess Road.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Beth Israel Deaconess Medical Center, please call 617-667-5661. For specific billing questions, dial 866-306-7643. This program is available across the Beth Israel Deaconess network.
What insurance does Beth Israel Deaconess Medical Center accept?
Beth Israel Deaconess Medical Center (BIDMC) accepts a wide range of insurance plans, including but not limited to Aetna, AllWays Health Partners, Blue Cross MA, Cigna, Fallon Commercial, Harvard Pilgrim Healthcare, MassHealth, Medicaid, Medicare, TRICARE/Health Net Federal Services, Tufts Health Plans, and United Healthcare. The hospital also accommodates various Medicare Advantage plans, managed care plans, indemnity plans, and Mass Health. For a comprehensive list of accepted insurance providers, please refer to the Beth Israel Deaconess Care Organization provider directory.
What awards or recognition has Beth Israel Deaconess Medical Center received?
Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts, is renowned for its high-quality cardiovascular care, evidenced by six American Heart Association Get With The Guidelines achievement awards. As a leading academic medical center, BIDMC consistently ranks as a national leader among independent hospitals in National Institutes of Health funding, showcasing its significant research efforts and achievements.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.